1. Home
  2. RVPH vs RAND Comparison

RVPH vs RAND Comparison

Compare RVPH & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • RAND
  • Stock Information
  • Founded
  • RVPH 2006
  • RAND 1969
  • Country
  • RVPH United States
  • RAND United States
  • Employees
  • RVPH N/A
  • RAND N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • RAND Finance: Consumer Services
  • Sector
  • RVPH Health Care
  • RAND Finance
  • Exchange
  • RVPH Nasdaq
  • RAND Nasdaq
  • Market Cap
  • RVPH 36.4M
  • RAND 38.1M
  • IPO Year
  • RVPH N/A
  • RAND N/A
  • Fundamental
  • Price
  • RVPH $1.18
  • RAND $16.40
  • Analyst Decision
  • RVPH Strong Buy
  • RAND
  • Analyst Count
  • RVPH 3
  • RAND 0
  • Target Price
  • RVPH $14.33
  • RAND N/A
  • AVG Volume (30 Days)
  • RVPH 283.9K
  • RAND 2.6K
  • Earning Date
  • RVPH 08-12-2024
  • RAND 08-06-2024
  • Dividend Yield
  • RVPH N/A
  • RAND 7.07%
  • EPS Growth
  • RVPH N/A
  • RAND 232.84
  • EPS
  • RVPH N/A
  • RAND 2.23
  • Revenue
  • RVPH N/A
  • RAND $7,553,884.00
  • Revenue This Year
  • RVPH N/A
  • RAND N/A
  • Revenue Next Year
  • RVPH N/A
  • RAND N/A
  • P/E Ratio
  • RVPH N/A
  • RAND $7.58
  • Revenue Growth
  • RVPH N/A
  • RAND 16.36
  • 52 Week Low
  • RVPH $0.95
  • RAND $12.50
  • 52 Week High
  • RVPH $6.80
  • RAND $19.60
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 45.21
  • RAND 53.83
  • Support Level
  • RVPH $0.95
  • RAND $15.45
  • Resistance Level
  • RVPH $1.30
  • RAND $17.79
  • Average True Range (ATR)
  • RVPH 0.14
  • RAND 0.60
  • MACD
  • RVPH 0.01
  • RAND 0.07
  • Stochastic Oscillator
  • RVPH 56.25
  • RAND 61.28

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

About RAND Rand Capital Corporation

Rand Capital Corp is a closed-end, diversified management company. The firm's investment objectives is to maximize the total return to the shareholders with current income combined with capital appreciation. Some of its portfolios include lumious, and GiveGab among others.

Share on Social Networks: